Anika Therapeutics

CompanyUnited StatesFounded 1992

RORWikidata

Anika Therapeutics develops one asset, in phase 3 (Orthovisc in aesthetic). Mostly other acting on CD44; based in the United States, founded in 1992.

1
Asset
Furthest stage
Phase 3
1
Trial
9
Signals

Pipeline

1
  • Orthovisc

    Dermal filler providing structural support and tissue augmentation

    Phase 3, Other, CD44, aesthetic, facial aesthetic treatment

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials1
  • Signals20
  • Similar companies4

Intelligence